跳至主要内容
临床试验/NCT05859971
NCT05859971已完成早期 1 期

Use of ICG-fluorescent Imaging for Sentinel Lymph Node Mapping in Patients With Breast Cancer

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年4月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Concordance Between Detection of Sentinel Lymph Nodes by ICG Versus Technetium-99, at the Lymph Node Level

研究概览

简要总结

The purpose of this research study is to assess the feasibility of using a different dye and imaging device, indocyanine green (ICG)-fluorescent imaging through the Asimov Imaging Platform, to perform sentinel lymph node biopsy.

Participants in this research study will be undergoing a sentinel lymph node biopsy as part of surgical treatment for breast cancer. Active participation will last through the post-operative visit.

详细描述

In this study, the sentinel lymph node biopsy will be performed with radioactive tracer (technetium-99 sulfur colloid) and blue dye, which is standard of care. Decisions will be made during surgery about which lymph nodes to remove using information from the radioactive tracer and blue dye alone.

For this research, ICG fluorescence dye during participant's surgery will also be used. After anesthesia has started, the ICG fluorescence dye will be injected in the breast along at the edge of the areola in the same location as the radioactive tracer and blue dye injections. The breast and axilla will then be imaged with the Asimov Imaging Platform to look for the sentinel lymph nodes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Diagnosis of clinical T1 or T2 breast cancer clinically node negative breast cancer requiring surgical lymph node evaluation
  • Surgery at University of Wisconsin Hospital and Clinic

排除标准

  • Pregnant: It is not known whether indocyanine green can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Women of child-bearing age will undergo a urine pregnancy test on the day of surgery, which is standard of care prior to anesthesia.
  • Breastfeeding: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when indocyanine green is administered to a nursing woman. Study team will exclude women who are breastfeeding.
  • Unable to provide informed consent
  • Allergy to indocyanine green
  • History of ipsilateral breast or axillary surgery

研究组 & 干预措施

Sentinel Lymph Node (SLN) mapping

Experimental

SLN mapping and biopsy will be performed using technetium-99m sulfur colloid and isosulfan blue dye, as well as ICG-fluorescent imaging.

干预措施: SLN mapping using technetium-99m +/- isosulfan blue dye (Drug)

Sentinel Lymph Node (SLN) mapping

Experimental

SLN mapping and biopsy will be performed using technetium-99m sulfur colloid and isosulfan blue dye, as well as ICG-fluorescent imaging.

干预措施: SLN mapping with ICG fluorescence using the Asimov Platform (Device)

结局指标

主要结局

Concordance Between Detection of Sentinel Lymph Nodes by ICG Versus Technetium-99, at the Lymph Node Level

时间窗: Day of operation

The study team will describe concordance rates between technetium-99 and ICG-fluorescence for each sentinel lymph node removed.

Concordance Between Detection of Sentinel Lymph Nodes by ICG Versus Technetium-99, at the Patient Level

时间窗: Day of operation

The study team will assess concordance rates at the patient level rates between technetium-99 and ICG-fluorescence.

次要结局

  • Accuracy of the ICG Mapping(Day of operation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验